Ulixacaltamide
Praxis Precision Medicines (PRAX)
Decision dateJan 29, 2027
75 days away
Marketer take
Essential tremor is a large neurology and primary-care population, so this would be a broad-reach launch compared with most rare-disease decisions.
- Sponsor company
- Praxis Precision Medicines (PRAX)
- Indication
- Essential tremor
- Therapeutic area
- Neurology
- Event
- PDUFA target action date
- Date
- Jan 29, 2027
- Status
- Upcoming
- Source
- company press release
- Last verified
- Nov 15, 2026
Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?